Is metformin a therapeutic paradigm for colorectal cancer: Insight into the molecular pathway?
Colorectal cancer (CRC) remains one of the major leading causes of cancer related morbidity and mortality. Apart from the conventional anti-neoplastic agents, metformin, a biguanide anti-diabetic agent, has recently found to have anti-cancer property. Several studies observed the effect of metformin...
| 發表在: | Current Drug Targets |
|---|---|
| 主要作者: | |
| 格式: | Review |
| 語言: | English |
| 出版: |
Bentham Science Publishers B.V.
2017
|
| 在線閱讀: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019587803&doi=10.2174%2f1389450118666161205125548&partnerID=40&md5=6a171daf9f53a3276a14e415d6366131 |